With 75427.0 shares changed hands, the volume of the stock remained lighter than its average volume of 90000.0 shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $17.63 whereas the lowest price it dropped to was $16.865. The 52-week range on NRC shows that it touched its highest point at $42.00 and its lowest point at $16.74 during that stretch. It currently has a 1-year price target of $44.00. With its current market cap of 407.07 million, NRC has annualized dividend of $0.48 while the current yield stands at 2.77%. Beta for the stock currently stands at 0.54.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NRC was down-trending over the past week, with a drop of -1.70%, but this was down by -8.69% over a month. Three-month performance dropped to -11.03% while six-month performance fell -22.59%. The stock lost -55.08% in the past year, while it has lost -1.70% so far this year.
Float and Shares Shorts:
At present, 23.48 million NRC shares are outstanding with a float of 14.70 million shares on hand for trading. On 2024-12-13, short shares totaled 0.35 million, which was 150.999995 higher than short shares on 1731628800. In addition to Mr. Michael D. Hays as the firm’s Founder, CEO, President & Director, Ms. Helen L. Hrdy serves as its Chief Operating Officer.
Institutional Ownership:
Through their ownership of 0.51727 of NRC’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, NRC reported revenue of $35819000.0 and operating income of $7980000.0. The EBITDA in the recently reported quarter was $9548000.0 and diluted EPS was $0.24.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
